INTRODUCTION
Endothelin-1 (ET-1), a peptide composed of 21 amino acids, is a potent vasoconstrictor originally identified in vascular endothelial cells [1] . In addition to its actions on smooth muscle, ET-1 has also been shown to elicit cell signalling in the myocardium. ET-1 induces atrial expression of atrial natriuretic factor (ANF) [2, 3] and brain natriuretic peptide (BNP) [4] , which regulate fluid and electrolyte metabolism and blood pressure homoeostasis. ET-1 also induces hypertrophy of isolated ventricular myocytes [5, 6] and may be involved in mechanical stretch-induced hypertrophy of isolated ventricular myocytes [7] . The endothelin receptor antagonists have been shown to reduce pressure overload- [8] or norepinephrine- [9] induced cardiac hypertrophy in i o. ET-1 also serves as a preconditioning agent against atrial and ventricular damage during ischaemiareperfusion injury [10, 11] . ET-1 has been shown to exert antiapoptotic activities in various cell types [12, 13] . More recently, anthracycline-induced cardiac myocyte injury was shown to be attenuated by ET-1 [14] , suggesting that ET-1 may induce antiapoptotic signalling in the heart. Therefore it is important to understand the mechanism of ET-1 signal transduction in cardiac myocytes.
GATA-4 is a member of the GATA family of zinc-finger transcription factors which play important roles in cell growth, differentiation and survival. Six GATA family members have been identified and shown to regulate transcription of target genes via binding to the consensus 5h-WGATAR-3h sequence. The GATA-4\5\6 subfamily is expressed in the heart. The GATA-binding sites have been identified in promoter regions of cardiac genes, including α-myosin heavy chain [15] , β-myosin heavy chain [16] , myosin light chains [17] , Na + \Ca# + exchanger [18, 19] , angiotensin II type "a receptor [20] , ANF [21] and BNP [22] . Many of these genes are up-regulated during cardiac Abbreviations used : ANF, atrial natriuretic factor ; BNP, brain natriuretic peptide ; EMSA, electrophoretic-mobility-shift assay ; ET-1, endothelin-1 ; λPPase, λ-protein phosphatase ; MAPK, mitogen-activated protein kinase ; MEK, MAPK kinase ; NFAT-3, nuclear factor of activated T-cells-3 ; PE, phenylephrine. 1 To whom correspondence should be addressed (e-mail ysuzuki!hnrc.tufts.edu).
phosphorylated. ET-1 activated the p44\42 mitogen-activated protein kinase (MAPK) and the MAPK kinase (MEK) within 3 min, and PD98059 (a specific inhibitor of MEK) abolished the ET-1-induced GATA-4 phosphorylation. PMA also caused the rapid activation of MAPK and the phosphorylation of GATA-4. In contrast, the activation of MAPK by phenylephrine or H # O # was weak and did not lead to GATA-4 phosphorylation. Thus ET-1 induces a GATA-4 phosphorylation by activating a MEK-MAPK pathway.
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hypertrophy and heart failure. The GATA elements are also found in promoters of genes which may be involved in antiapoptotic activities such as bcl-x [23] , nitric oxide synthases [24, 25] and glutathione peroxidase [26] .
The regulatory mechanisms of GATA-4 may involve posttranslational modifications. Molkentin et al. [27] proposed a signal-transduction pathway for GATA-4 activation involving calcineurin and nuclear activator of T-cells-3 (NFAT-3). In this pathway, the Ca# + \calmodulin-activated calcineurin induces dephosphorylation and migration of NFAT-3 into the nucleus, which, in turn, interacts with GATA-4. The treatment with the calcineurin inhibitor cyclosporin blocked the development of cardiac hypertrophy induced by pressure overload or genetic manipulations [27, 28] . Recently, Morimoto et al. [29] demonstrated that the α-adrenergic agonist phenylephrine (PE) induced the serine phosphorylation of GATA-4, suggesting that GATA-4 is also regulated via the phosphorylation mechanism.
The HL-1 cardiac-muscle cell line was established from transgenic mouse atria expressing the simian-virus-40 large T antigen [30] . These immortalized cells maintain the differentiated atrial myocyte phenotype and the ability to contract. We studied the effects of ET-1 on the GATA-4 transcription factor in HL-1 cells and found that ET-1 rapidly phosphorylated and activated GATA-4. The signalling mechanism of ET-1-induced GATA-4 phosphorylation appears to involve a mitogen-activated protein kinase (MAPK)-MAPK kinase (MEK) pathway. 
EXPERIMENTAL

Electrophoretic-mobility-shift assay (EMSA)
To prepare nuclear extracts, the cells were washed in PBS and incubated in 10 mM Hepes (pH 7.8)\10 mM KCl\2 mM MgCl # \ 0.1 mM EDTA\0.1 mM PMSF\5 µg\ml leupeptin\10 µg\ml aprotinin\1 mM sodium fluoride\0.1 mM sodium orthovanadate\1 mM tetrasodium pyrophosphate for 15 min at 4 mC. Triton X-100 (Sigma) was then added at a final concentration of 0.6 % (v\v). The samples were mixed vigorously, and centrifuged. The pelleted nuclei were resuspended in 50 mM Hepes (pH 7.8)\50 mM KCl\300 mM NaCl\0.1 mM EDTA\ 0.1 mM PMSF\5 µg\ml leupeptin\10 µg\ml aprotinin\1 mM sodium fluoride\0.1 mM sodium orthovanadate\1 mM tetrasodium pyrophosphate\1 % (v\v) glycerol, then mixed for 20 min and centrifuged at 15 800 g for 5 min. The supernatants were harvested, and protein concentrations determined [31] .
To perform EMSA, binding reaction mixtures contained nuclear extract (2 µg of protein), 0.5-1 µg of poly(dIdC):poly(dI-dC), 1 mM EDTA, 0.5-1 mM dithiothreitol and 0.25 ng ( 20 000 c.p.m.) of $#P-labelled double-stranded oligonucleotide containing consensus GATA sequence (5h-CAC TTG ATA ACA GAA AGT GAT AAC TCT-3h) in either 20 mM Tris\HCl (pH 7.5)\100 mM NaCl\10 % (v\v) glycerol [32] or 5 mM Tris\HCl (pH 7.5)\37.5 mM KCl\4 % (w\v) Ficoll 400 [29] . Binding reactions were performed for 20 min at 25 mC. An electrophoresis of samples through a native 6 % (w\v) polyacrylamide gel was followed by autoradiography.
Supershift experiments were performed by incubating 2 µg of anti-GATA-4, anti-GATA-6 or anti-NFAT-3 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) in the binding reaction mixture for 1 h at 4 mC before the addition of the $#P-labelled oligonucleotide to start the binding reaction.
A densitometry analysis of the bands was performed using the Sigma gel software. All the experiments were repeated at least three times.
Western-blot analysis
To prepare lysates, the cells were washed in PBS and solubilized with 50 mM Hepes solution, pH 7.4, containing 1 % (v\v) Triton X-100, 4 mM EDTA, 1 mM sodium fluoride, 0.1 mM sodium orthovanadate, 1 mM tetrasodium pyrophosphate, 2 mM PMSF, 10 µg\ml leupeptin and 10 µg\ml aprotinin. Following centrifugation in a Microfuge, protein concentrations in the supernatant were determined [31] . Cell lysates (10 µg of protein) were electrophoresed through a reducing SDS\10 % (w\v) polyacrylamide gel and electroblotted on to a nitrocellulose membrane. After the transfer, the gel was stained with Coomassie Blue to check for transfer efficiency. The membrane was blocked and incubated with the polyclonal IgG for phospho-specific p44\42 MAPK (New England Biolabs, Beverly, MA, U.S.A.), p44\42 MAPK (Santa Cruz Biotechnology), phospho-specific MEK1\2 (New England Biolabs) or MEK1 (Zymed Laboratories, South San Francisco, CA, U.S.A.). The levels of proteins and phosphoproteins were detected with horseradish peroxidaselinked secondary antibodies and the ECL2 (enhanced chemiluminescence) System (Amersham Life Science, Arlington Heights, IL, U.S.A.). The membranes were stained with Coomassie Blue to confirm the equal loading and transfer. SDS\PAGE (10 % gel) was used to separate phosphorylated from non-phosphorylated GATA-4, and the gel contained acrylamide and bisacrylamide in the ratio 30 : 0.165. For a Western-blot analysis, the gel was electroblotted on to a PVDF membrane, and the rabbit polyclonal IgG for GATA-4 (H-112) (Santa Cruz Biotechnology) was used at a concentration of 1 µg\ml. In these experiments, 20 µg of protein of nuclear extracts were loaded on to a gel. To determine the effects of γ-protein phosphatase (λPPase), nuclear extracts were isolated as described above, except that the phosphatase inhibitors (sodium fluoride, sodium orthovanadate and tetrasodium pyrophosphate) were omitted. Nuclear extracts (20 µg) were incubated with 2500 units\ml λPPase (New England Biolabs) at 30 mC for 30 min before subjecting them to SDS\PAGE.
RESULTS
EMSA revealed that the nuclear extracts from HL-1 cells had some constitutive binding activity towards the consensus GATA sequence. The supershift experiments using the GATA-4 antibody revealed that this GATA binding protein was GATA-4 ( Figure 1A ). Neither the anti-GATA-6 antibody nor a control IgG caused a supershift of the GATA band (results not shown). The GATA-4 binding activity was enhanced by the treatment of cells with ET-1 (30 nM) for 10 min. Furthermore, the complex between DNA and ET-1-activated GATA-4 migrated slightly more slowly than the complex with unstimulated GATA-4 ( Figure 1A) . Activation of the DNA-binding activity and the reduced mobility of GATA-4 induced by ET-1 was also observed when we used an EMSA protocol similar to that employed by Morimoto et al. [29] (Figure 1B ). This protocol decreased smearing, and thus the reduced migration was more clearly visible. The ET-1-mediated increase in GATA-4 DNA binding activity and the shift of DNA-GATA-4 complex were transient, occurring as early as 3 min ( Figure 1C) .
A two-hybrid screen with a GATA-4 bait showed that GATA-4 can form a complex with NFAT-3 [27] . Thus the upward EMSA shift (Figure 1) could result from the formation of such a complex. However, an anti-NFAT-3 antibody did not supershift the GATA-4 band (results not shown). The absence of interactions of GATA-4 with NFAT-3 in the mechanism of ET-1-mediated upward shift of the GATA-4 band was further supported by our observation that the upward shift can also be detected by reducing-SDS\PAGE. As shown in Figure 2(A) , two GATA-4 bands were separated at $ 50 kDa in an immunoblot analysis using the anti-GATA-4 antibody. In untreated cells the lower band was slightly denser than the band with reduced mobility (see leftmost lane, Figure 2A ). The treatment of cells with ET-1 resulted in an upward shift of the lower band. By 10 min of treatment, all of the GATA-4 protein molecules existed as a single species with reduced mobility (lane 2 from the left, Figure 2A) . To test the hypothesis that GATA-4 may be phosphorylated and thus give slightly reduced mobility, we incubated nuclear extracts with λPPase in in itro. The treatment of nuclear extracts from ET-1-treated cells with λPPase completely abolished the higher band (lane 4 from the left, Figure 2A ). Similar results were obtained in EMSA exper-GATA-4 phosphorylation by endothelin-1
Figure 1 Activation of GATA-4 by ET-1
(A) HL-1 cells were treated with ET-1 (30 nM) for 10 min. Nuclear extracts were prepared and subjected to an EMSA with the 32 P-labelled oligonucleotide containing GATA-binding sequence in the reaction mixtures with 20 mM Tris/HCl, 100 mM NaCl and 10 % (v/v) glycerol as described by Suzuki et al. [32] . For the supershift experiments, nuclear extracts were subjected to an EMSA in the presence of the antibody (Ab) for GATA-4 (2 µg). (B) Nuclear extracts were subjected to an EMSA with the 32 P-labelled oligonucleotide containing the GATA-binding sequence in reaction mixtures with 5 mM Tris/HCl, 37.5 mM KCl and 4 % (w/v) Ficoll 400 as described by Morimoto et al. [29] . (C) HL-1 cells were treated with ET-1 (30 nM) for 3, 10 or 30 min. Nuclear extracts were prepared and subjected to an EMSA [29] with the 32 P-labelled oligonucleotide containing the GATA-binding sequence. The histogram (lower right) indicates fold increases in the intensity of GATA bands after treating cells with ET-1, as determined by densitometry. The values represent meanspS.E.M. (n l 4-6).
Figure 2 Effects of λPPase on ET-1-induced GATA-4 activation
Nuclear extracts from HL-1 cells treated with ET-1 (30 nM) for 10 min were incubated in vitro at 30 mC without or with λPPase (2500 units/ml). These samples were subjected to (A) SDS/PAGE and Western-blot analysis using the antibody for GATA-4 or (B) an EMSA using the protocol described by Suzuki et al. [32] . Figure 2B ). These results demonstrate that ET-1 induced the phosphorylation of GATA-4.
iments (
Towatari et al. [33] reported that interleukin 3 activated GATA-2 through the p44\42 MAPK pathway. GATA-4 also contains putative MAPK phosphorylation sites [34] , and Morimoto et al. [29] demonstrated that PE induced phosphorylation of GATA-4. Therefore we hypothesized that ET-1 phosphorylated GATA-4 through the MAPK pathway. It has been shown that ET-1 can activate MAPK in neonatal rat ventricular myocytes [35, 36] . Consistently, the treatment of HL-1 cells with ET-1 caused a rapid phosphorylation of p44\42 MAPK ( Figure 3A ) and MEK ( Figure 3C ) within 3 min of treatment. The protein levels of MAPK or MEK were unchanged in response to ET-1 treatment (results not shown). Figure 3(B) shows the ratio of phosphorylated MAPK and MAPK proteins as determined by densitometry analysis.
To determine the role of the MAPK pathway in ET-1-signalling for GATA-4 phosphorylation, we used a specific inhibitor of MEK activation, PD98059 [37] . The treatment of HL-1 cells with PD98059 (30 µM) inhibited phosphorylation of p44\42 MAPK induced by ET-1 (results not shown), suggesting that ET-1 activated MAPK via MEK. As shown in Figure 4(A) , the pretreatment of cells with PD98059 effectively blocked the upward shift (phosphorylation) of the GATA-4 band induced by ET-1. Further, EMSA experiments showed that PD98059 abolished the upward shift induced by ET-1 ( Figure 4B ). Densitometry analysis revealed that ET-1-induced increase in the GATA DNAbinding activity was also blocked by PD98059 ( Figure 4C) .
Recently, Morimoto et al. [29] reported that PE induced the MAPK-dependent phosphorylation of GATA-4 in neonatal rat
Figure 4 Role of a MEK-MAPK pathway in GATA-4 phosphorylation
(A) HL-1 cells were pretreated with 30 µM PD98059 (PD) for 30 min then treated with ET-1 for 10 min. Nuclear extracts were prepared and subjected to SDS/PAGE and Western-blot analysis using the antibody for GATA-4. (B) Nuclear extracts were subjected to an EMSA using the protocol described by Morimoto et al. [29] . (C) The bar graph indicates meanspS.E.M. of the intensity of the GATA-4 bands as determined by densitometry. The asterisk (*) denotes the values that were significantly different from each other at P 0.05. PD98059 was dissolved in DMSO and an equal volume of DMSO (0.2 % final concn.) alone had no effect. ventricular myocytes. To determine if PE also phosphorylates GATA-4 in HL-1 cells, cells were treated with ET-1 (30 nM) or PE (10 or 100 µM). In contrast with the ET-1 treatment, which caused a rapid phosphorylation of GATA-4, the treatment of HL-1 cells with PE for 3, 10 or 30 min failed to elicit GATA-4 phosphorylation ( Figure 5A ). Results of these EMSA experiments were confirmed by Western-blot analysis, as neither 10 µM PE ( Figure 5B ) nor 100 µM PE (results not shown) caused the upward shift of GATA-4 band. Since both ET-1 and PE are known activators of MAPK in neonatal ventricular myocytes [35] , these results raised the question of whether MAPK activation alone may not be sufficient to elicit an early phase GATA-4 phosphorylation. To address this issue, the HL-1 cells were treated with PMA, another known activator of MAPK in neonatal ventricular myocytes [35] and in HL-1 cells [38] . An EMSA ( Figure 6A ) and Western-blot analysis ( Figure 6B) showed that, similarly to ET-1, PMA caused the rapid phosphorylation of GATA-4 in HL-1 cells. By examining the abilities of ET-1, PE and PMA to activate p44\42 MAPK, we found that ET-1 and PMA were much stronger stimuli compared with PE ( Figure 7A) . Furthermore, H # O # , which only weakly activated MAPK (Figure 7A ), did not cause a GATA-4 phosphorylation ( Figure 7B ). These results suggest that, in Figure 5 Effect of PE on GATA-4 phosphorylation HL-1 cells were treated with ET-1 (30 nM) or PE (10 or 100 µM) for the times indicated. Nuclear extracts were prepared and subjected to (A) an EMSA [29] and (B) Western-blot analysis.
Figure 6 Effects of PMA on GATA-4 phosphorylation
HL-1 cells were treated with PMA (10 nM) for 10 min. Nuclear extracts were prepared and subjected to (A) an EMSA [32] and (B) Western-blot analysis.
HL-1 cells, ET-1 and PMA activated MAPK strongly enough to phosphorylate GATA-4.
DISCUSSION
We describe here a signalling pathway in cardiac muscle in which ET-1 rapidly phosphorylates GATA-4. ET-1 also activated MEK and p44\42 MAPK, and the ET-1-mediated phosphorylation of GATA-4 was blocked by a MEK inhibitor, indicating that ET-1 activated the MEK-MAPK-GATA-4 pathway.
Important GATA-binding sites have been identified in multiple cardiac-specific transcriptional regulatory regions, and the overexpression of GATA-4 has been shown to transactivate these elements. GATA-4 regulates various genes involved in cardiac hypertrophy, blood-pressure regulation and cell survival. Since GATA-4 phosphorylation by endothelin-1
Figure 7 Effects of H 2 O 2 on MAPK activation and GATA-4 phosphorylation
(A) HL-1 cells were treated with PE (100 µM) for the time indicated or with ET-1 (30 nM), PMA (10 nM) or H 2 O 2 (100 µM) for 5 min. Cell lysates were prepared and the phosphorylation of p44/42 MAPK was monitored by Western-blot analysis using the phospho-specific p44 and p42 MAPK antibody. The membrane was stripped by incubating in 100 mM glycine, pH 2.5, for 1 h and re-blotted with the antibody for p44/42 MAPK proteins. (B) HL-1 cells were treated with ET-1 (30 nM) or H 2 O 2 (100 µM) for the times indicated. Nuclear extracts were prepared and subjected to an EMSA [29] .
ET-1 has also been shown to regulate these processes, ET-1 signalling for GATA-4 activation may play important roles in cardiac biology.
GATA-1 and GATA-2 have been shown to be phosphorylated in non-cardiac muscle cells [33, 39] , and GATA-4 contains putative phosphorylation sites [34] . Morimoto et al. [29] recently showed that PE induced a serine phosphorylation of GATA-4. Consistent with these findings, our experiments using λPPase showed that ET-1 induced phosphorylation of GATA-4. Since λPPase is capable of dephosphorylating serine, threonine and tyrosine residues, these experiments did not determine which residues were phosphorylated by ET-1. The treatment of cells with ET-1 induced the activation of MEK and p44\42 MAPK with the time course of activation similar to the phosphorylation of GATA-4. The ET-1-mediated GATA-4 phosphorylation was effectively abolished by a specific inhibitor of MEK, PD98059, indicating a signal-transduction pathway from MEK-MAPK to GATA-4. The GATA-4 molecule contains a number of putative MAPK phosphorylation sites, including Ser"!&, which is within the preferential Pro-Xaa-Ser\ Thr-Pro MAPK phosphorylation sequence. We are presently performing mutagenesis studies to identify the site(s) which is (are) phosphorylated in response to ET-1.
Morimoto et al. [29] recently reported that PE activated serine phosphorylation of GATA-4 via MAPK pathway in neonatal rat ventricular myocytes. In contrast with the rapid phosphorylation by ET-1 shown in the present study, a PE-induced phosphorylation occurred after 3 h of treatment. Consistent with the findings by Morimoto et al. [29] , PE did not elicit a rapid phosphorylation of GATA-4 in HL-1 cells. The mechanism of the different actions on GATA-4 between ET-1 and PE may involve different extents of MAPK activation by these agents. As shown in Figure 7 , the PE-induced activation of MAPK was weaker than that elicited by ET-1. PMA, which caused activation of MAPK similar to that elicited by ET-1, also induced the phosphorylation of GATA-4. In contrast, H # O # which, like PE, weakly activated MAPK, did not elicit rapid GATA-4 phosphorylation. In summary, the present study demonstrates that ET-1 rapidly induces the phosphorylation of GATA-4 via the MEK-MAPK pathway in an HL-1 adult atrial-muscle cell line. The present results, along with those from a previous study on neonatal rat ventricular myocytes [29] , indicate that the phosphorylation of GATA-4 may regulate the GATA-dependent transcription of various genes involved in cardiac-muscle pathophysiology.
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